This transcript has been typed at speed, and therefore may contain
mistakes. Newsnight accepts no responsibility for these. However, we will be happy to correct serious errors.
Who owns the map of the human body? 12/2/01
SUSAN WATTS:
Wherever we look, our world has
been conquered. We've trodden its
contours, mapped its every detail
and understand what it holds. Today,
a new exploration has begun - the
exploration of ourselves.
Scientists have had a rough map of
our genes since last summer, but
only now are they beginning to make
sense of this new terrain. It's turning
out to be an exhilarating journey.
DAVID BALTIMORE:
President, California Institute of Technology
Shivers ran down my spine because I
realised that we were seeing human
beings opened to investigation with
a depth we'd never seen before.
JOHN SULSTON:
International Human Genome Project
This is an iconic moment when we
say we've got to this point - it's
only the beginning not the end, in
fact it's only halfway through the
beginning.
WATTS:
There will have been a
lot of strain on printers around
the world today as researchers got
their first sight of the scientific
papers describing the human genetic
sequence. Papers like this are the
essence of science but today's are
different - two sets of papers
extraordinary for their size and
for what they describe. I found
just printing them out
a problem, let alone trying to make
sense of it all. One set is the
official version of the human DNA
code. The other is a rival version
from a commercial company. The
alpha males of each team are sworn
enemies. Their two philosophies
couldn't be more different. It was
supposed to be the best kept secret
in science but this weekend that
broke down. Not only did news of
today's findings leak out, but what
should have been a celebration of a
great moment in scientific history
descended into bitter acrimony. At
press briefings today, the row erupted.
In London, the man at the helm of the
publicly funded team said
the genome should belong to no one
individual or company, and that the
commercial team's version draws
heavily on the public work. He
thanked the charities
and governments that had paid for
the project.
SULSTON:
Without that, not only
would we have a privatised genome,
but we would not have a genome at
all.
WATTS:
Craig Venter, the man at the
head of the commercial project,
says he's charging scientists
because he's added value to the
data. Ignoring the row, he tried to
focus on the science and made
profound connections between the
sequence and the nature of humanity.
CRAIG VENTOR:
Our understanding of the human
genome has changed in fundamental
ways. The small number of genes -
just 30,000 genes instead of
140,000 supports the notion that
we're not hard-wired, We now know
the notion that one gene leads to
one protein and perhaps one disease
is false.
WATTS:
Even the tale of the way
these papers have been published is
a bloody one. The public team has
its findings in this week's issue
of Nature magazine. The commercial
project is published in the rival
US journal - Science magazine. UK
scientists accuse the American
publisher of bowing to the
restrictive terms of a commercial
outfit but the magazine says it's
just being pragmatic.
SULSTON:
It's depressed me all along that there's
not a completely altruistic view to
the way the genome's being handled
It's not a matter of sniping -
it's not a game. This is about
important issues - the release and
use of our genome. It's not
something you can switch off
overnight - if people want to put
restrictions on that then I'm
afraid I have to say I don't agree.
If you call that sniping, fine, but
I don't. I think it's just telling
the truth as I see it.
WATTS:
This very public row has threatened to
overshadow the actual science in
today's papers and there are some
real surprises even for hard-bitten
scientists for whom human genes are
familiar territory. Each of us is
made up of trillions of cells.
Inside each cell are 23 pairs of
chromosomes. The chromosomes are
numbered - 1 to
22 - then the last pair determines
your sex. Our genes are strung
along the double helix of DNA
contained within these 23 pairs of
chromosomes. Each gene is made up
of chemicals of which there are
four types - A,C,T and G - the
letters of the DNA code. It takes 3
billion of these letters to code
for a human being. Scientists at
the Sanger Centre near Cambridge
decoded about a third of the genome.
They deciphered the first human
chromosome here just over a year
ago. Although they suspected we
have fewer genes than originally
thought, they were still surprised
to learn we have only twice as many
as a fly. The obvious question then
is how come we're so much more
complex. A fly can fly, but
generally they can't talk, or think
a great deal. If it's not down to
the number of genes, what is it
that makes us different? The man
who's led the UK effort for the
past decade thinks the key is in
the way we "manage" our genes.
SULSTON:
With all animals with lots of cells,
including flies and worms, you need
managers to organise how one cell
is different from another. They are
the executive structure. In flies
and worms, you have
a certain executive structure. In
going from them to humans, what you
build more than anything else is
the executive structures. You get
many more layers of management -
people reporting to each other - in
genetic terms. We know that because
we can look in there and see that
the extra genes in humans compared
to flies and worms belong more in
the management class than in any
other class. What we don't know is
how those managers fit together.
That's what we'll find out now.
WATTS:
Finding out we have only twice as
many genes as a fruit fly might be
a good lesson in humility, but does
it tell us anything useful? Well,
for scientists it confirms
long-held suspicions that what
really makes us individuals is
decided not in our genes in
themselves but in the way our
bodies interpret these genes and
that's the next 50 years of biology.
The other perhaps humbling
discovery about our DNA is that
about 10% of our genes are very
similar to those of bacteria. In
fact, our code is a sort of
evolutionary history book. Some of
the oldest sections date back 100
million years. For the Nobel prize
winner David Baltimore, the most
intriguing finding is the
suggestion that we actually
recruited these genes into our code
to do something useful.
BALTIMORE:
It's remarkable that some of our genome
seems to have jumped from bacteria
into vertebrates without going
through the evolutionary trail of
most of the rest of the DNA. That
indicates that periodically in the
lives of people, DNA actually jumps
from bacteria into us.
SULSTON:
This again reminds us of the unity of life -
the fact that genes are not
purpose-made for each organism, but
rather evolution keeps on re-using
its inventions over time. And it
was known that this occasionally
happened, but suddenly the scale is
much greater - there's hundreds of
genes that have come that way. Some
people might find that scary, that
we're exchanging DNA with bacteria
all the time. We have to get used
to this idea. Nature is not very
prophylactic in what it does.
WATTS:
But the genome is much more than
a window on our past - it's about
finding genetic clues to real
diseases and designing drugs for
real people. Perhaps even
personalising medicine - moving
away from the one-drug-suits-all
approach. Eventually, for some
scientists, it's about making a
decent profit too. Some of this
profit will come from scientists
search for genetic differences
between people. Single letter
changes - "snips" - in the 3
billion-letter code. These changes
provide clues about how susceptible
we each might be to disease.
DR DAVID BENTLEY:
Head of Human Genetics, The Sanger Centre
A snip is a single alteration in one
letter of the alphabet between two
individual copies of the human
genome. The recent discovery has
been mapping out of some two
million of these snips across the
genome, scattered throughout all
our genes. The tremendous
opportunity this provides is to
begin to look at how these
variations between individuals are
responsible for disease, how we
react to our environment, drugs and
so on.
WATTS:
It's not just the drug
companies but each and every one of
us who will find our lives affected
in some way be the project.
BALTIMORE:
It's going to affect everyone in the
world because the way we do
medicine, the ways we think about
intelligence, the ways we structure
our educational systems - all those
things are going to be affected by
our understanding of the human
genome.
WATTS:
Just as we've moved on from
learning we were not at the centre
of the Universe so we'll also cope
with knowing we have only a few
more genes than the simpler creatures.
And the very fact that we've begun to
make sense of our own genetic code
goes to show it's not the number of
genes that counts, but how you use them.